Immune response and inflammation in cancer health disparities
- PMID: 34965905
- PMCID: PMC8930618
- DOI: 10.1016/j.trecan.2021.11.010
Immune response and inflammation in cancer health disparities
Abstract
Cancer death rates vary among population groups. Underserved populations continue to experience an excessive burden of lethal cancers that is largely explained by health-care disparities. However, the prominent role of advanced-stage disease as a driver of cancer survival disparities may indicate that some cancers are more aggressive in certain population groups than others. The tumor mutational burden can show large differences among patients with similar-stage disease but differences in race/ethnicity or residence. These dissimilarities may result from environmental or chronic inflammatory exposures, altering tumor biology and the immune response. We discuss the evidence that inflammation and immune response dissimilarities among population groups contribute to cancer disparities and how they can be targeted to reduce these disparities.
Keywords: African American; cancer disparity; immune response; inflammation.
Copyright © 2021. Published by Elsevier Inc.
Conflict of interest statement
Declaration of interests No interests are declared.
Figures



References
-
- Sung H, et al., Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 2021. 71(3): p. 209–249. - PubMed
-
- National Cancer Institute. SEER Cancer Stat Facts: prostate cancer. 2021; Available from: http://seer.cancer.gov/statfacts/html/prost.html.
-
- DeSantis CE, et al., Cancer statistics for African Americans, 2019. CA Cancer J Clin, 2019. 69(3): p. 211–233. - PubMed
-
- National Cancer Institute. SEER Cancer Stat Facts: breast cancer. 2021. November 17, 2021; Available from: https://seer.cancer.gov/statfacts/html/breast.html.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical